(Q63547911)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12589646%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12589646%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12589646%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

Peter B Illei

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12589646%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Marc Ladanyi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12589646%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Maureen F Zakowski

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12589646%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12589646%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12589646%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12589646%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12589646%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

51-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12589646%20AND%20SRC:MED&resulttype=core&format=json

Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma: utility of combined E-cadherin and calretinin immunostaining

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Cytology: screening or diagnostic tool?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Diagnostic problems in serous effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma. Review and update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Calretinin: A Novel Immunocytochemical Marker for Mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

E-cadherin, N-cadherin, and calretinin in pleural effusions: the good, the bad, the worthless

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Numerical abnormalities of chromosomes 7, 18, and x in precancerous breast disease defined by fluorescent in situ hybridization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Significance of epithelial membrane antigen in the work-up of problematic serous effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

p53 immunostaining is a highly specific and moderately sensitive marker of malignancy in serous fluid cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Markers for metastatic adenocarcinoma in serous effusion specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

p53 expression is common in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

p53 immunohistochemistry for distinguishing reactive mesothelium from low grade ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

The separation of benign and malignant mesothelial proliferations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10923

7 January 2021

Identifiers

DOI

10.1002/CNCR.10923

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12589646%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference